Neeter C, Thomeé R, Silbernagel K G, Thomeé P, Karlsson J
Sportrehab-Physical Therapy and Sports Medicine Clinic, Göteborg, Sweden.
Scand J Med Sci Sports. 2003 Dec;13(6):376-82. doi: 10.1046/j.1600-0838.2003.00305.x.
The purpose of this double-blind study was to evaluate the effects of iontophoresis with dexamethazone to iontophoresis with saline solution on patients who had acute (less than 3 months) pain from the Achilles tendon, in terms of range of motion, muscular endurance, pain and symptoms. Twenty-five patients (15 men and 10 women), aged between 18 and 76 years (mean=38), were evaluated before and after 2 weeks of treatment with iontophoresis, as well as after 6 weeks, 3 and 6 months and 1 year. Two groups were treated for 2 weeks with iontophoresis for each treatment. Three ml of dexamethazone were used for the experiment group (n=14) and 3 ml of saline solution for the control group (n=11). Both groups then followed the same rehabilitation programme for 10 weeks. Good reliability was found for the toe-raise and range of motion tests. Poor reliability was, however, found for the pain on palpation test, which was therefore excluded. No difference was found between or within groups for the toe-raise test. Several significant improvements were seen in the experiment group but not in the control group, in the range of motion test, pain during and after physical activity, pain during walking and walking up and down stairs, morning stiffness and tendon swelling. Even though the small sample size limits the possibilities to draw definite conclusions, we conclude from the present study, using a double-blind, randomised approach and a 1-year follow-up period, that positive effects from using iontophoresis with dexamethazone were found in the treatment of patients with acute Achilles tendon pain.
这项双盲研究的目的是评估地塞米松离子导入法与生理盐水离子导入法对患有急性(少于3个月)跟腱疼痛患者在活动范围、肌肉耐力、疼痛及症状方面的影响。25名年龄在18至76岁(平均38岁)之间的患者(15名男性和10名女性)在接受离子导入治疗2周前后、以及在6周、3个月、6个月和1年后接受了评估。两组患者每种治疗均接受2周的离子导入治疗。实验组(n = 14)使用3毫升地塞米松,对照组(n = 11)使用3毫升生理盐水。然后两组均遵循相同的康复计划10周。发现提踵和活动范围测试具有良好的可靠性。然而,触诊疼痛测试的可靠性较差,因此将其排除。提踵测试在组间和组内均未发现差异。在活动范围测试、体育活动期间及之后的疼痛、行走及上下楼梯时的疼痛、晨僵和肌腱肿胀方面,实验组有几项显著改善,而对照组则没有。尽管样本量小限制了得出明确结论的可能性,但我们通过本研究,采用双盲、随机方法和1年随访期得出结论,使用地塞米松离子导入法治疗急性跟腱疼痛患者有积极效果。